Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. (OCUL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ocul · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 19 Wall Street analysts in the past 3 months
Buy
19 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$30.00
Consensus
$30.00
+265.9% upside
Low
$30.00
Median: $30 · Last Close: $8.20
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.02 | ↓ 2.15% |
1-day model range: $7.97–$8.07. Peak: $8.07 (-2.15%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $7 | -14.0% |
| 2028 | $7 | -20.6% |
| 2029 | $6 | -23.9% |
| 2030 | $6 | -25.7% |
| 2031 | — | -26.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OCUL · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | Clear Street | Maintains | Buy→Buy |
| 2026-02-20 | Needham | Maintains | Buy→Buy |
| 2026-02-18 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-08 | Needham | Maintains | Buy→Buy |
| 2025-11-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ocular Therapeutix, Inc. (OCUL) stock. Of the recent 86 rating actions, 6 were upgrades and 5 were downgrades. 19 analysts currently cover OCUL.
Analyst Recommendation Trends
OCUL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$52M
↓ 79.7% YoY
Revenue Next Year
$111M
↑ 113.7% YoY
EPS This Year
$-1.55
EPS Next Year
$-1.45
↓ 6.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast OCUL EPS of $-1.55 for the current fiscal year, based on estimates from 6 analysts. The OCUL revenue forecast is $52M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OCUL stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OCUL price target is $30.00 (+265.9% upside), with an analyst consensus of Buy.
The OCUL short-term stock prediction for tomorrow is $8.02 (-2.15%). The OCUL stock price prediction for 2027 estimates an average of $7. The OCUL stock prediction for 2030 projects a range of $6–$7.
Ocular Therapeutix, Inc. trades on NASDAQ under the ticker OCUL. The OCUL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
OCUL forecast · 8 questionsAccording to 19 Wall Street analysts, the average 12-month OCUL price target is $30.00, with a high forecast of $30.00 and a low of $30.00. The median price target is shown in the chart above when available. This implies +265.9% potential upside from the current price of $8.20.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.